Fibogest H 250mg Injection
Marketer
Fibovil Pharmaceuticals Pvt Ltd
Salt Composition
Hydroxyprogesterone (250mg)
Overview Fibogest H 250mg Injection
Preterm labor can be mitigated in pregnant women using Fibogest H 250mg Injection, thereby decreasing the likelihood of premature delivery. This injection also helps prevent miscarriage and subsequent preterm births in women with a history of premature delivery. Administration is strictly by or under a physician's direct supervision, following their prescribed dosage and duration. Continued use is vital as directed. Common side effects include injection site reactions, nausea, pruritus, diarrhea, and skin rashes. Report any persistent discomfort to your doctor; management strategies exist. Regular blood glucose monitoring is crucial due to potential blood sugar fluctuations. Immediately consult your physician if you experience jaundice, dark urine, or abdominal pain. Prior to treatment, disclose any history of circulatory problems, diabetes, liver conditions, or other medications you're currently using, as interactions may impact efficacy or alter the drug's effects.
Primary Ingredients of Fibogest H 250mg Injection
No text provided to rephrase.
Uses of Fibogest H 250mg Injection
Avoiding Early Birth
Major Benefits of Fibogest H 250mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
Common Side effects of Fibogest H 250mg Injection:
- Injection site pain
- Injection site swelling
- Red spots or bumps
- Rash
How to use Fibogest H 250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Fibogest H 250mg Injection works:
Fibogest H 250mg injection contains a progestogen, a type of female hormone.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fibogest H 250mg Injection may pose unknown risks. Physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The injectable medication Fibogest H 250mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Fibogest H 250mg Injection poses minimal risk during lactation. Research in human subjects indicates negligible transfer to breast milk, suggesting no infant harm.
DrivingSAFE
Fibogest H 250mg injections typically do not impair driving ability.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Fibogest H 250mg Injection's efficacy and safety in individuals with renal impairment. Medical advice is recommended. The drug's progesterone component may induce fluid retention in those with pre-existing kidney conditions.
LiverUNSAFE
Patients with liver disorders should likely avoid Fibogest H 250mg Injection due to potential safety concerns. A physician's consultation is recommended.
What if you forget to take Fibogest H 250mg Injection :
Should you forget a scheduled dose of the Fibogest H 250mg Injection, seek medical advice.
Facts to Know About Fibogest H 250mg Injection
| Label | Value |
|---|---|
| Chemical Type | Glucocorticoids, Mineralocorticoids, and Progestins |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
| Active Class | First-Generation Progestins |


